David Hyman

David Hyman is the Chief Medical Officer of Loxo Oncology at Eli Lilly. David was previously an Associate Professor of Medicine at Weill Cornell Medicine from January 2015 to December 2019, and an Associate Member at Memorial Sloan Kettering Cancer Center from January 2009 to January 2020. Prior to that, they were a Medicine Resident at New York Presbyterian Hospital from July 2006 to July 2009.

David Hyman is an MD who graduated from Joan & Sanford I. Weill Medical College of Cornell University. David also has a BS in Biology from Brown University. David is certified by the American Board of Internal Medicine in Medical Oncology and Internal Medicine.

David Hyman reports to Daniel M. Skovronsky, SVP & Chief Scientific Officer.